Quick Answer
Cartesian Therapeutics, Inc. reported Common Stock Shares Outstanding of 26.01 million shares for the year ending 2025.
- Cartesian Therapeutics, Inc. showed an increase of +0.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Cartesian Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Cartesian Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 1,096.8%.
- Historical annual values: Fiscal year 2025: 26.01 million shares | Fiscal year 2024: 25.77 million shares | Fiscal year 2023: 5.40 million shares | Fiscal year 2022: 153.04 million shares | Fiscal year 2021: 123.62 million shares | Fiscal year 2020: 108.07 million shares | Fiscal year 2019: 86.33 million shares | Fiscal year 2018: 22.47 million shares | Fiscal year 2017: 22.34 million shares | Fiscal year 2016: 18.44 million shares | Fiscal year 2015: 2.17 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: